Literature DB >> 10955946

Interstitial cystitis and ileus in pediatric-onset systemic lupus erythematosus.

H Tanaka1, S Waga, T Tateyama, T Nakahata, T Ito, K Sugimoto, Y Kakizaki, K Tomimoto, M Yokoyama.   

Abstract

A girl aged 11 years presented with autoimmune hemolytic anemia with thrombocytopenia, and subsequently developed severe abdominal pain, vomiting, and pollakiuria. X-ray findings of her abdomen demonstrated paralytic ileus with intestinal wall thickening. Intravenous pyelography revealed bilateral hydroureter with mild hydronephrosis and contracted bladder. Pathological examination of her bladder revealed interstitial cystitis, with evidence of focal deposition of IgG and C3 in a granular pattern on small blood vessel walls. She was diagnosed as having systemic lupus erythematosus (SLE) associated with paralytic ileus and chronic interstitial cystitis. Although initiation of high-dose prednisolone therapy resulted in a gradual improvement in clinical symptoms, reducing the dosage of prednisolone caused a relapse. To our knowledge, the combination of paralytic ileus and chronic interstitial cystitis is quite uncommon in pediatric-onset SLE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955946     DOI: 10.1007/s004679900285

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  3 in total

1.  Dramatic development of severe SLE in a patient with an incomplete disease.

Authors:  G Fabio; M Carrabba; C Hu; M Floriani; C Besana
Journal:  Rheumatol Int       Date:  2005-01-21       Impact factor: 2.631

2.  Two complications in patients with systemic lupus erythematosus: lupus cystitis and lupus enteritis.

Authors:  Gang Wang; Ning Zhuo; Feng Tian; Jingyang Li; Zhenhua Wen
Journal:  Arch Med Sci       Date:  2022-04-20       Impact factor: 3.707

3.  Interstitial cystitis and systemic lupus erythematosus in a 20-year-old woman.

Authors:  Maria do Socorro Teixeira Moreira Almeida; Luciano Lima Carvalho; Amanda Gualberto Carvalho; João Vicente Moreira Almeida; Jeany Borges e Silva
Journal:  Rheumatol Int       Date:  2008-08-12       Impact factor: 3.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.